Cargando…
Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR(®) trial
BACKGROUND: Although COPD exacerbations are known to occur more frequently in winter, there is little information on hospitalizations and cause-specific mortality. This study aimed to examine seasonal variations in mortality and exacerbations in patients with COPD during the TIOtropium Safety and Pe...
Autores principales: | Wise, Robert A, Calverley, Peter MA, Carter, Kerstine, Clerisme-Beaty, Emmanuelle, Metzdorf, Norbert, Anzueto, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819585/ https://www.ncbi.nlm.nih.gov/pubmed/29497289 http://dx.doi.org/10.2147/COPD.S148393 |
Ejemplares similares
-
Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
por: Calverley, Peter MA, et al.
Publicado: (2017) -
Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial
por: Dusser, Daniel, et al.
Publicado: (2016) -
Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
por: Putcha, Nirupama, et al.
Publicado: (2022) -
The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes
por: Anzueto, Antonio, et al.
Publicado: (2015) -
Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial
por: Dahl, Ronald, et al.
Publicado: (2015)